Factors associated with anxiety and depression among patients with chronic obstructive pulmonary disease

AS Jarab, WA AlQerem, SR Abu Heshmeh… - Expert Review of …, 2024 - Taylor & Francis
Objectives This study investigated factors associated with anxiety and depression in COPD
outpatients. Methods A cross-sectional study of 702 COPD outpatients from two major …

Diagnosis and management of asthma in the elderly

N Scichilone, C Pedone, S Battaglia, C Sorino… - European journal of …, 2014 - Elsevier
Bronchial asthma is one of the most common chronic diseases worldwide, and by definition
not expected to recover with aging. However, the concept that asthma can affect older …

Management of allergic disease in the elderly: key considerations, recommendations and emerging therapies

MT Ventura, N Scichilone, M Gelardi… - Expert review of …, 2015 - Taylor & Francis
The number of people over 65 is increasing around the world. At present, between 5 and
10% of allergic diseases affect the elderly. In particular, rhinitis is increasing worldwide; the …

[HTML][HTML] Cardiovascular diseases in COPD: from diagnosis and prevalence to therapy

A Papaporfyriou, K Bartziokas, D Gompelmann… - Life, 2023 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is considered one of the leading causes of
mortality. Cardiovascular comorbidities are diagnosed often in COPD patients, not only …

Targeting eosinophils in chronic respiratory diseases using nanotechnology-based drug delivery

P Sharma, DS Dhanjal, C Chopra… - Chemico-Biological …, 2022 - Elsevier
Abstract Asthma, COPD, COVID-19, EGPA, Lung cancer, and Pneumonia are major chronic
respiratory diseases (or CRDs) affecting millions worldwide and account for substantial …

New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19

MM El Tabaa, MM El Tabaa - European Journal of Pharmacology, 2020 - Elsevier
Abstract Nowadays, coronavirus disease 2019 (COVID-19) represents the most serious
inflammatory respiratory disease worldwide. Despite many proposed therapies, no effective …

Treatment of chronic obstructive pulmonary disease with roflumilast, a new phosphodiesterase 4 inhibitor

NJ Gross, MA Giembycz, SI Rennard - COPD: Journal of Chronic …, 2010 - Taylor & Francis
Recent advances in chronic obstructive pulmonary disease (COPD) treatment offer symptom
relief, but disease modification remains an unmet goal of pharmacotherapy. Reducing the …

[HTML][HTML] Clinical efficacy and safety of Chinese herbal medicine versus placebo for the treatment of chronic obstructive pulmonary disease: A systematic review and …

C Xiong, Y Li, G Zhuang, Y Zeng, H Wei, C Li… - … Therapies in Medicine, 2021 - Elsevier
Objective Randomized clinical trials and published meta-analyses assessing the clinical
effectiveness of Chinese herbal medicine (CHM) on the treatment of stable chronic …

Adverse drug reactions: treatment burdens and nurse‐led medication monitoring

ME Gabe, GA Davies, F Murphy… - Journal of Nursing …, 2011 - Wiley Online Library
Gabe me, Davies ga, Murphy f., Davies m., Johnstone l. & Jordan s.(2011) Journal of
Nursing Management 19, 377–392 Adverse drug reactions: treatment burdens and nurse …

Inhaled bronchodilators and the risk of tachyarrhythmias

CH Lee, S Choi, EJ Jang, HM Yang, HI Yoon… - International Journal of …, 2015 - Elsevier
Background/objectives There have been controversies about whether inhaled
bronchodilators could increase the risk of clinically important tachyarrhythmias. We …